EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction

Xiaoning Gao iD, Wuyan Guo, Peiyuan Liu, Mingyue Yuwen, Hongyu Ren, Shengtao Hu, Zixiang Liu, Ruyang Tan, Kairui Liu, Zhiru Yang, Junli Ba, Xue Bai und 9 weitere

eLife · 2026

DOI: 10.7554/elife.97632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Xiaoning Gao und 20 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Tianjin University, Tianjin, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Kelch-Like ECH-Associated Protein 1, Ethanol, Capsaicin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Key Medical Discipline Construction Project, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive alcohol consumption poses significant health risks and is closely associated with oxidative damage. The KEAP1-NRF2-ARE signaling pathway serves as the primary antioxidant system. However, current small molecule inhibitors are all covalently bound to KEAP1, meaning that once bound, they are not easily dissociated, while continuous inhibition of KEAP1 exhibits severe side effects. In this study, BLI, CETSA, Pull-down, Co-IP, and HDX-MS assay analysis were conducted to detect the KEAP1 binding behavior of natural product, capsaicin (CAP), both in vitro and in cells. The ethanol-induced acute gastric mucosal damage rat model was also established to evaluate the therapeutic effect of CAP. Our findings demonstrated that CAP mitigated mitochondrial damage, facilitated the nuclear translocation of NRF2, leading to the up-regulation of downstream antioxidant response elements, HMOX1, TXN, GSS, and NQO1 in GES-1 cells. Furthermore, CAP directly bind to KEAP1 and inhibit the interaction between KEAP1 and NRF2. In the KEAP1-knockout 293T cells, CAP failed to activate NRF2 expression. We identified that CAP non-covalently bound to the Kelch domain and allosterically regulated three specific regions of KEAP1: L342-L355, D394-G423, and N482-N495. To improve drug solubility and delivery efficiency, we developed IR-Dye800 modified albumin-coated CAP nanoparticles. The nanoparticles significantly reduced the gastric mucosal inflammation and activated NRF2 downstream genes in vivo. Our hypothesis was further verified our hypothesis in Nrf2-knockout mice. This study provides new insights that CAP is a safe and novel NRF2 agonist by allosterically regulating KEAP1, which may contribute to the development of lead drugs for oxidative stress-related illness, e.g., aging, cancer, neurodegenerative, and cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1EthanolCapsaicinOxidative StressGastric MucosaAnimalsHumansRatsMaleProtein BindingMiceRats, Sprague-DawleySignal TransductionHEK293 CellsCell Line

Stichwörter der Autor:innen

KEAP1allosteric regulationcapsaicincell biologymouseoxidative stress

Substanzen

NF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1EthanolCapsaicinKEAP1 protein, ratKEAP1 protein, human

Autor:innen und Institutionen

  • School of Life Sciences, Tianjin University, Tianjin, China.
  • Tianjin JiAnKang Bio and TCM-technology Development Co, Ltd, Tianjin, China.
  • CAS and THHDG (Tianjin) Rural Revitalization Industry Development Co, Ltd, Tianjin, China.
  • Peiyang Park Campus, Tianjin University, Tianjin, China.
  • Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Re…
  • Institute for TCM-X, MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist, Department of Automation, Tsinghua University, Beijing, China.

ORCID-Profile: Xiaoning Gao, Cheng Zhu, Jun Kang

Förderung

  • Tianjin Key Medical Discipline Construction Project
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Gao, X., Guo, W., Liu, P., Yuwen, M., Ren, H., Hu, S., Liu, Z., Tan, R., Liu, K., Yang, Z., Ba, J., Bai, X., Shama, S., Tang, C., Miao, K., Pei, H., Liu, L., Zhu, C., Wang, T., …, & Kang, J. (2026). Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction. eLife. https://doi.org/10.7554/elife.97632

Vancouver

Gao X, Guo W, Liu P, Yuwen M, Ren H, Hu S, et al. Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction. eLife. 2026. doi:10.7554/elife.97632

BibTeX
@article{Gao2026,
  author = {Gao, Xiaoning and Guo, Wuyan and Liu, Peiyuan and Yuwen, Mingyue and Ren, Hongyu and Hu, Shengtao and Liu, Zixiang and Tan, Ruyang and Liu, Kairui and Yang, Zhiru and Ba, Junli and Bai, Xue and Shama, Shiti and Tang, Cong and Miao, Kai and Pei, Haozhi and Liu, Liren and Zhu, Cheng and Wang, Tao and Zhang, Bo and Kang, Jun},
  title = {Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction},
  journal = {eLife},
  year = {2026},
  doi = {10.7554/elife.97632}
}
Kostenlos starten →